ponogen (DSP 1944) / Dong Sung Pharma - LARVOL DELTA

Dongsung Bio Pharm and LifePhotonic Sign Deal for Cancer Treatment Innovation [Google translation] (Business Korea) - "Dongsung Bio Pharm announced on Jan. 7 that it has signed an exclusive agreement with Germany's LifePhotonic for the use of its self-developed photosensitizer DSP 1944 (Ponogen) in clinical trials for pancreatic cancer treatment and peritoneal cancer diagnosis using the Diffuser Laser Probe....'With this agreement, we have taken a step closer to our goal of commercializing pancreatic cancer treatment and peritoneal cancer diagnostics by 2028'....Dongsung Bio Pharm is currently conducting Phase 2 clinical trials in Korea for the pancreatic cancer treatment indication. These trials are essential for assessing the efficacy and safety of DSP 1944 (Ponogen) and are a critical step towards regulatory approval and eventual commercialization."

Commercial • Pancreatic Cancer • Peritoneal Cancer